Symphony Holdings Limited provides consolidated earnings guidance for the year ended December 31, 2013. For the period, the company expects to record a consolidated profit attributable to the owners of the company of approximately HKD 15 million. This profit is mainly attributable to the reversal (amounting to approximately HKD 80 million in aggregate) of the foreign exchange reserves resulting from the discontinued manufacturing operations and also a gain (amounting to approximately HKD 29 million in aggregate) due to the acquisition of China Ocean Resources Limited and disposal of Grand Wealth Group Limited.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 HKD | 0.00% | -1.25% | -7.06% |
23/05 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
23/05 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
1st Jan change | Capi. | |
---|---|---|
-7.06% | 305M | |
+10.52% | 147B | |
+13.12% | 78.69B | |
+0.51% | 46.64B | |
-18.92% | 42.89B | |
+3.56% | 27.65B | |
+14.68% | 14.26B | |
+3.02% | 12.8B | |
+12.80% | 9.54B | |
+5.81% | 8.05B |
- Stock Market
- Equities
- 1223 Stock
- News Symphony Holdings Limited
- Symphony Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2013